AngioDynamics is a leading provider of innovative medical devices used by interventional radiologists, interventional cardiologists, surgeons, and other physicians for the minimally-invasive diagnosis and treatment of cancer and peripheral vascular disease.
Founded in Queensbury in 1988, AngioDynamics and has grown into a NASDAQ-listed public company. Having distinguished itself as a dynamic brand in a technologically competitive, high-growth industry, AngioDynamics sells its products in the U.S. through a direct sales force, and in international markets through a combination of direct sales and distributors.
Through acquisitions of companies such as Navilyst Medical, RITA Medical Systems and Oncobionic, as well as Diomed and FlowMedica, AngioDynamics now boasts a diverse product line that includes market-leading radiofrequency ablation and NanoKnife® systems, NAMIC® fluid management products, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products, venous products and targeted renal therapy products.
AngioDynamics has distinguished itself through the company's consistent ability to successfully develop and bring to market new technologies and products, and believes it is well poised to continue that trend. Looking into the future, the Company plans to bring forth a continuing stream of innovations that greatly improve patient care by providing the highest-quality, best-performing products.